BioSpace News Archive

Genetown

Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets

Abpro to receive up to $1.1 billion, including a $30 million upfront equity investment, clinical funding, milestones, and royalties

March 3, 2020
·
5 min read
Deals

Vifor Pharma Secures a Second Investment Grade Rating From Fitch Ratings

Vifor Pharma announced that Fitch Ratings has initiated coverage of Vifor Pharma with an investment grade BBB- credit rating and a stable outlook.

March 3, 2020
·
2 min read
Drug Development

Targovax Announces Completed Enrollment in the ONCOS-102 Trial in Anti-PD1 Refractory Melanoma

Targovax ASA announces that it has completed patient enrollment in the phase I trial with ONCOS-102 in combination with Keytruda in patients with advanced anti-PD1 checkpoint inhibitor refractory melanoma.

March 3, 2020
·
2 min read
Genetown

PureTech Announces First Participant Dosed in Clinical Trial of Wholly-Owned Lymphedema Candidate LYT-100

Multiple ascending dose and food effect study will be a follow-up to a previously conducted single ascending dose clinical trial of LYT-100

March 3, 2020
·
6 min read
Transgene and BioInvent to Present Data on BT-001, an Oncolytic Virus Encoding for an Anti-CTLA4 Antibody, at Upcoming Congresses

Oncolytic Virus Design and Preclinical Data to be Presented at ESMO TAT, IO Summit Europe, Keystone Symposium and AACR 2020

March 3, 2020
·
7 min read
BioMidwest

Rapid Dx for Life Starts Global Deployment of Mobile Diagnostic Labs

Mobile Diagnostic Labs will soon be heading to a community near you to test for the novel coronavirus Covid-19.

March 3, 2020
·
1 min read
AO, icotec Join Forces on New Spinal Stabilization System

The AO Foundation and icotec ag announce the successful agreement and kick-off for the joint development of a new spinal stabilization system based on icotec’s proprietary BlackArmor® Carbon/PEEK composite implant material.

March 3, 2020
·
2 min read
BioInvent and Transgene to Present Data on BT-001, an Oncolytic Virus Encoding for an Anti-CTLA4 Antibody, at Upcoming Congresses

Oncolytic virus design and preclinical data to be presented at ESMO TAT, IO Summit Europe, Keystone Symposium and AACR 2020

March 3, 2020
·
7 min read
Business

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2019 Financial Results and Host Conference Call and Webcast on March 13, 2020

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced it that it will report its fourth quarter and year-end 2019 financial results on Friday, March 13, 2020.

March 3, 2020
·
1 min read
BARDA Upsizes its Contract with MediWound Awarding an Additional $5.5 Million for Emergency Readiness for NexoBrid DeploymentTotal non-dilutive funds for NexoBrid now valued at over $200 million

MediWound Ltd. announced that the U.S. Biomedical Advanced Research and Development Authority has expanded its awarded contract with MediWound providing supplemental funding of $5.5 million to support emergency readiness for NexoBrid deployment upon request of use of NexoBrid in mass casualty situation.

March 3, 2020
·
6 min read